Hello, everyone, and how are you this fine, sunny morning? The middle of the week has arrived, as you may know, so why not celebrate with a delicious cup of stimulation? We are enjoying almond toffee, for those who like to live vicariously, and invite you to join us. And why not? The neurons can always use a little help, so why deny them? Speaking of assistance, here are some tidbits to get you started. Hope your day is productive and rewarding, and of course, do keep in touch …

The Trump administration announced it would name Ned Sharpless, the director of the National Cancer Institute, as the acting commissioner of the Food and Drug Administration next month, STAT says. The announcement came just a week after the current commissioner, Scott Gottlieb, announced he plans to resign in early April. Sharpless, a physician and scientist, ran the Lineberger Comprehensive Cancer Center at the University of North Carolina before taking over at the NCI in October 2017.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!


What is it?

STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • Online intelligence briefings
  • Frequent opportunities to engage with veteran beat reporters and industry experts
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy